Pacífico Holding

Pacifico Holding is a Sao Paulo-based investor focused on private healthcare transformation through software and efficient management systems, writing Series A and Series B checks in the $1M to $5M range. The positioning is sector-specific in a useful way: healthcare is the thesis rather than one of many sectors, and the fund’s lens skews toward Brazilian private healthcare operations, where there is genuine appetite for software that improves margins, reduces administrative cost, and modernizes legacy hospital and clinic management. Healthcare relevance is concentrated in health IT, RCM, hospital and clinic operations software, payer-side analytics, and AI applications that automate clinical or operational workflows. Founders pursuing pure consumer wellness, biotech, or care delivery brick-and-mortar should look elsewhere. The right founder is a Brazilian technical or commercial operator with a credible product, real revenue, and a plan to land Brazilian hospital or operadora customers as anchor accounts. Pacifico’s positioning makes it most useful when a founder has worked through Pre-Seed and Seed and is building toward category leadership in Brazilian private healthcare. Geographic advantage is the Brazilian healthcare operator network. Pacifico’s ability to introduce founders to private hospital networks, operadoras, and large clinic groups is the differentiated value beyond the check. Best entry is a warm intro from a portfolio founder, an existing Brazilian healthcare operator, or a known LatAm co-investor that has worked with the fund. Cold inbound is read but conversion is lower. Lead the pitch with revenue, willingness-to-pay evidence from real Brazilian customers, and a sober view on hospital sales cycles, which routinely consume nine to eighteen months. Be explicit about LGPD posture, ANS dynamics where relevant, and how AI quality is monitored in production for clinical-adjacent products. Caveats: at $1M to $5M check sizes for Series A and B, Pacifico is often a co-lead rather than a sole anchor in larger rounds, so founders should clarify the lead structure early. Brazilian healthcare’s payer concentration in operadoras like Bradesco Saude, Hapvida, and SulAmerica means a single contract decision can swing a year of revenue, and savvy investors model that risk explicitly. Ask Pacifico about reserves, prorata behavior, and which Series B and C leads have followed it into portfolio companies. Reference checks with current portfolio CEOs on commercial introductions and operating support are essential. Used appropriately, Pacifico is one of a small number of Brazilian healthcare-focused growth-stage partners; for sector-agnostic generalist Series A capital, founders have more options.